PCT at a glance
PureCycle Technologies, Inc. (PCT, SEC CIK 1830033) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 17, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), PureCycle Technologies, Inc. (PCT) reported revenue of $8.4 million and a net loss of $182.6 million. Diluted EPS was -$1.21.
- As of September 30, 2026, 28 institutional investment managers tracked by SignalX reported holding PureCycle Technologies, Inc. (PCT) shares worth $207.9 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Olson Dustin on November 16, 2026 of 220,000 shares at $1.69 per share.
- In the last 90 days, PCT insiders reported 3 open-market purchases ($569K) and 0 open-market sales ($0) on Form 4, a net purchase of $569K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $8.4M
- 10-K XBRL
- Insiders · 90 days
- 3 buys · 0 sells
- Net +$569K
- 13F holders
- 28 funds
- $207.9M · −4 vs prior quarter
- Latest 8-K
- Nov 4, 2026
- Item 2.02 · Item 5.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- Newly expanded risks triggered by June 2026 Convertible Senior Notes and Common Stock offerings
- Debt $469.1 million at September 30, 2026, with covenant breaches potentially accelerating maturities
- Environmental compliance exposure: prior wastewater violations could lead to fines, permit revocation, or plant shutdown
- Ironton Facility execution risk: filter fouling and maintenance downtime threaten production volumes and customer commitments
- Customer qualification delays could postpone commercial revenue despite executed offtake agreements
Management Discussion & Analysis
- Cash and marketable securities $193.0M vs $181.7M at December 31, 2025
- Operating cash used $125.0M vs $114.1M YoY, driven by production, legal and Ironton Turnaround costs
- Financing provided $178.2M, including $287.5M notes and $163.0M stock proceeds
- Debt repurchase $216.0M principal for $246.3M cash, generating $34.5M extinguishment loss
- Outlook dependent on Ironton improvement, PureFive commercialization and additional financing for planned facilities
AI summary of the PCT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Press release announces PureCycle Technologies’ third-quarter results for the period ended September 30, 2026
- Investor presentation also contains information relevant to the reported financial results
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Fernando Musa becomes Executive Chairman November 3, 2026, supporting CEO Dustin Olson on Ironton commercial activities and strategic execution
- Leadership transition replaces Chairman Dan Coombs, who remains a director, while Tanya Burnell continues as Lead Independent Director
Item 7.01: Regulation FD Disclosure
- Investor presentation scheduled for November 4, 2026
- Exhibit 99.2 provides the company’s investor messaging and may shape near-term market expectations
Item EX-99.1: Item EX-99.1
- Q3 revenue $2.3M, down from $4.5M in Q2, reflecting Ironton disruptions and New Jersey delays to approximately 50M pounds of food-contact demand
- Ironton production 5.2M pounds, up 14% sequentially, but below 7.3M pounds in Q3 2025; resolved issues now constrain output less than current demand
Item EX-99.2: Item EX-99.2
- Q3 production rose to 5.2MM lbs, but operational issues constrained revenue to $2.3MM versus $4.5MM in Q2
- Commercial pipeline reached 45–55MM lbs/year at full ramp, approaching 40–50% utilization
Item 2.03: Creation of a Direct Financial Obligation
- Item 2.03 points to Item 1.01 for details on PureCycle’s new direct financial obligation
- Investor impact depends on the referenced agreement’s borrowing amount, interest rate, maturity and repayment terms
Item 1.01: Entry into a Material Definitive Agreement
- $200 million revolving credit facility maturity extended one year, from September 30, 2027 to September 30, 2028
- Maturity extension fee creates an incremental financing cost for PureCycle
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 financial results for quarter ended June 30, 2026 announced
- Investor presentation provides additional operating and financial context
Item EX-99.2: Item EX-99.2
- Q2 revenue $4.5MM, up from $1.7MM, marking the sixth consecutive quarter of sequential growth
- Ironton turnaround completed ahead of schedule and below budget, with throughput reaching 12,000 pounds per hour
Item 7.01: Regulation FD Disclosure
- Investor presentation scheduled for August 6, 2026, signaling an upcoming management update
- Exhibit 99.2 contains the substantive disclosure and may shape investor expectations across PCT securities
Item EX-99.1: Item EX-99.1
- Q2 revenue $4.5M, up 173% YoY, supported by first P&G deliveries and six new commercial partnerships
- Commercial adoption advancing: seven customer conversions, Downy caps in production, Tide caps targeted for Q3 retail production
AI summaries of PCT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for PCT
Don't miss the next PCT filing
- Alerts as it files. A push when PCT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut PCT, by share count.
- Ask anything. An AI agent that reads every PCT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Olson Dustin | Buy | Nov 16, 2026 | 220,000 | $1.69 |
| Musa Fernando | Buy | Nov 13, 2026 | 57,600 | $1.71 |
| Musa Fernando | A | Nov 3, 2026 | 153,374 | - |
| Kalter Brad | F | Sep 23, 2026 | 2,830 | $5.15 |
| Musa Fernando | Buy | Sep 4, 2026 | 15,479 | $6.38 |
| Kalter Brad | O | Aug 24, 2026 | 50,000 | - |
| Olson Dustin | F | Aug 5, 2026 | 11,149 | $6.87 |
| SYLEBRA CAPITAL LLC | D | Jun 15, 2026 | - | $1050.00 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $0 | $0 | $8.4M |
| Operating Income | -$113.9M | -$145.4M | -$181.4M |
| Net Income | - | -$289.1M | -$182.6M |
| Op. Margin | - | - | -2171.6% |
| Net Margin | - | - | -2185.1% |
| Balance Sheet | |||
| Total Assets | - | $798.4M | $922.7M |
| Equity | $420.2M | $180.4M | $45.9M |
| ROE | - | -160.2% | -397.9% |
| Per Share | |||
| EPS | - | $-1.75 | $-1.21 |
| Cash Flow | |||
| Operating CF | - | -$144.8M | -$142.7M |
| CapEx | $153.9M | $55.6M | $40.8M |
Source: XBRL data in PureCycle Technologies, Inc. (PCT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate PCT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 28 | $207.9M |
| Q2 2026 | 32 | $324.4M |
| Q1 2026 | 30 | $190.1M |
| Q4 2025 | 27 | $369.7M |
| Q3 2025 | 28 | $570.9M |
| Q2 2025 | 25 | $560.2M |
| Q1 2025 | 22 | $186.6M |
| Q4 2024 | 20 | $244.4M |
- Citadel Advisors LLC+3.03M (+1294%)
- Millennium Management+1.62M (+1106%)
- BlackRock+1.11M (+10%)
- PNC Financial Services+420.8K (+26%)
- Renaissance Technologies LLC+371.6K (+89%)
- Bank of America Corp−167.1K (-27%)
- Invesco Ltd−140.3K (-65%)
- Morgan Stanley−86.7K (-4%)
- Citigroup−51.7K (-52%)
- OLD NATIONAL BANCORP /IN/−10.8K (-4%)
- Equitable Holdings Inc−111.8K
- Marex Group plc−52.8K
- Blackstone Group−26.9K
- FMR LLC (Fidelity)−9.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 212 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
PCT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 4, 2026 | - | - | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 8, 2026 | - | - | - |
| 8-K | Aug 31, 2026 | - | Analysis | - |
| 4 | Aug 25, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Jul 23, 2026 | - | - | - |
| 4 | Jun 16, 2026 | - | - | - |
| 8-K | Jun 15, 2026 | - | Analysis | - |
| 8-K | Jun 11, 2026 | - | Analysis | - |
| 4 | May 21, 2026 | - | - | |
| 4 | May 21, 2026 | - | - | |
| 4 | May 13, 2026 | - | - | |
| 4 | May 13, 2026 | - | - | |
| 8-K | May 11, 2026 | - | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 17, 2026 | - | Analysis | - |
| 4 | Mar 24, 2026 | - | - | - |
Related Health Care companies
- ASIX · AdvanSix Inc.Plastic Materials, Synth Resins & Nonvulcan Elastomers
- ROG · ROGERS CORPPlastic Materials, Synth Resins & Nonvulcan Elastomers
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
PCT SEC filings: frequently asked questions
Are PCT insiders buying or selling?
In the last 90 days, PureCycle Technologies, Inc. (PCT) officers, directors and 10% owners reported 3 open-market purchases worth $569,052 by 2 insiders and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold PCT stock?
As of September 30, 2026, the largest PureCycle Technologies, Inc. (PCT) holders among the 13F filers tracked by SignalX were BlackRock ($53.8 million), Vanguard Portfolio Management LLC ($36.5 million), Vanguard Capital Management LLC ($34.1 million), State Street Corp ($15.5 million), Citadel Advisors LLC ($14.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was PCT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), PureCycle Technologies, Inc. (PCT) reported revenue of $8.4 million and a net loss of $182.6 million. Diluted EPS was -$1.21. The figures come from the XBRL data in the 10-K.
What did PCT report in its latest 8-K?
PureCycle Technologies, Inc. (PCT) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Appointment of Directors or Principal Officers) and Item 7.01 (Regulation FD Disclosure). Press release announces PureCycle Technologies’ third-quarter results for the period ended September 30, 2026.
What are the latest PCT SEC filings?
PureCycle Technologies, Inc. (PCT) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 17, 2026.
What is PCT's SEC CIK number?
PureCycle Technologies, Inc. (PCT)'s SEC Central Index Key (CIK) is 1830033. EDGAR lists every PCT filing under that number.
Ask anything about PCT
The research agent reads PCT's filings, financials, insider trades and 13F holders, then answers with sources.